| NCT ID | NCT06092814 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Pennsylvania |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2024-07-12 |
| Primary Completion | 2028-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2024-07-12 with a primary completion date of 2028-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to see if transcranial alternating current stimulation (tACS) can be used to enhance language abilities in people with post-stroke aphasia. Participants will receive real and sham tACS in conjunction with various language tests. Researchers will compare the post-stroke aphasia group with aged matched controls to see if brain response to tACS differs between groups.
Eligibility Criteria
Inclusion Criteria for Persons with Aphasia: 1. Presence of aphasia 2. Suffered a single, left hemisphere stroke 3. Stroke ≥6 months old (chronic) at the time of enrollment Inclusion Criteria for Healthy Controls: 1. Right-handedness 2. Must be able to understand the nature of the study, and give informed consent Exclusion criteria for Persons with Aphasia: 1. Inability to understand the nature of the study 2. Marked naming impairment 3. Impaired non-verbal, conceptual processing 4. History of significant medical or neurological disorder (other than stroke) 5. History of significant or poorly controlled psychiatric disorders 6. Current abuse of alcohol or drugs, prescription or otherwise 7. Nursing a child, pregnancy, or intent to become pregnant during the study 8. Clinically significant hearing loss 9. Contraindications to tACS 10. Contraindications to MRI Exclusion Criteria for Healthy Controls 1. Diagnosis of a neurodegenerative disease or clinically significant cognitive complaint 2. Any unrelated neurologic or physical condition that impairs communication ability 3. History of unrelated neurological conditions including but not limited to traumatic brain injury, stroke, or small vessel disease that has resulted in a neurologic deficit 4. Any additional neurological condition that would likely reduce the safety of study participation, including central nervous system (CNS) vasculitis, intracranial tumor, intracranial aneurysm, multiple sclerosis or arteriovenous malformations 5. A medically unstable cardiopulmonary or metabolic disorder 6. Terminal illness associated with survival \<12 months 7. Major active psychiatric illness that may interfere with required study procedures or treatments as determined by the enrolling physician 8. Current abuse of alcohol or drugs, prescription or otherwise 9. Contraindications to tACS 10. Contraindications to MRI
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06092814 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06092814 currently recruiting?
Yes, NCT06092814 is actively recruiting participants. Contact the research team at danielas@pennmedicine.upenn.edu for enrollment information.
Where is the NCT06092814 trial being conducted?
This trial is being conducted at Philadelphia, United States.
Who is sponsoring the NCT06092814 clinical trial?
NCT06092814 is sponsored by University of Pennsylvania. The trial plans to enroll 120 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.